ArticleJournal of hematology & oncology2022

Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia.

Nicole Bäumer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.